Compliance Radar
Who was sanctioned, and for what?
Fines, court rulings and incidents from Europe and North America: 718 cases from 32 jurisdictions, each with an official source and checked against that source before publication. Filter by country, area of law and sector. Click a chart to drill down one level.
Click a bar to drill down one level.
Where?
by authority- Europäische Kommission €1.33bn 100 % · 5 cases
What for?
by topicWho?
by sectorAll sectors
When?
per quarter, by date of decision| Period | Cases | Total |
|---|---|---|
| Q3 2023 | 0 | — |
| Q4 2023 | 1 | €13.4m |
| Q1 2024 | 0 | — |
| Q2 2024 | 0 | — |
| Q3 2024 | 0 | — |
| Q4 2024 | 1 | €462.6m |
| Q1 2025 | 0 | — |
| Q2 2025 | 2 | €787m |
| Q3 2025 | 0 | — |
| Q4 2025 | 1 | €72m |
| Q1 2026 | 0 | — |
| Q2 2026 | 0 | — |
| Q3 2026 | 0 | — |
5 cases
15 Dec 2025 Exide, FET (inkl. Elettra), Rombat, EUROBAT (Clarios Kronzeuge)EU: 72 million EUR against starter battery manufacturers and the association EUROBAT €72m
From 2005 to 2017, the manufacturers of automotive starter batteries agreed, with the help of the association EUROBAT, to publish jointly calculated lead surcharges (EUROBAT premiums) and to use them in price negotiations with carmakers. Fines: Exide 30 million EUR, Rombat 20.218 million EUR, Elettra 15.594 million EUR, FET 6.11 million EUR, EUROBAT 125,000 EUR; Clarios escaped a fine as leniency applicant.
Suppliers may pass on raw material surcharges individually, but must never fix them in an industry-wide coordinated manner via association indices.
Joint raw material surcharges among competitors via association indices
- Authority / court
- Europäische Kommission
- Area of law
- Competition law · Cartels and collusion
- Legal basis
- Art. 101 AEUV, Art. 53 EWR-Abkommen
- Action
- Fine
- Status of proceedings
- unknown
- Sector
- Automotive
- Mitigating circumstances
- Leniency programme (Clarios 100 %, FET 50 %, Rombat 30 %); reduction for inability to pay for one company; payment in instalments
Checked against the official source on 25 Sep 2026 · Direct link
Report an error
2 Jun 2025 Delivery Hero SE, Glovoapp23 SAEU: 329 million EUR against Delivery Hero and Glovo – first labour market cartel €329m
From July 2018 to July 2022, Delivery Hero and Glovo agreed a mutual no-poach arrangement, exchanged commercially sensitive information and allocated national markets; this was facilitated by Delivery Hero's minority stake in Glovo. Fines: Delivery Hero 223.285 million EUR, Glovo 105.732 million EUR (settlement procedure, 10 % reduction).
No-poach clauses and information flows from stakes in competitors are high-risk under competition law and must be shielded by clean-team rules.
No-poach agreements and information exchange via minority stakes
- Authority / court
- Europäische Kommission
- Area of law
- Competition law · Cartels and collusion
- Legal basis
- Art. 101 AEUV, Art. 53 EWR-Abkommen
- Action
- Fine
- Status of proceedings
- unknown
- Sector
- Retail and e-commerce
- Employees
- 10,000 or more
- Mitigating circumstances
- Settlement procedure (10 % reduction)
- Kommission verhängt Geldbußen in Höhe von 329 Mio. EUR gegen Delivery Hero und Glovo (IP/25/1356) Press release of an authority
Checked against the official source on 25 Sep 2026 · Direct link
Report an error
1 Apr 2025 BMW, Ford, Honda, Hyundai/Kia, Jaguar Land Rover, Mazda, Mitsubishi, Opel/GM, Renault/Nissan, Stellantis, Suzuki, Toyota, Volkswagen, Volvo, ACEA (Mercedes-Benz Kronzeuge)EU: 458 million EUR against carmakers and ACEA over end-of-life vehicle recycling cartel €457.9m
The Commission imposed fines of around 458 million EUR on 15 carmakers and the association ACEA. From 2002 to 2017, they had agreed not to pay dismantlers for recycling end-of-life vehicles and not to advertise recycling rates or recycled content; ACEA organised the meetings. Mercedes-Benz received full immunity as leniency applicant, and all parties reached a settlement (10 % reduction).
Agreements on purchasing terms or on refraining from advertising claims are also cartels – association meetings require antitrust supervision.
Agreements in association bodies; refraining from purchasing or advertising can also be a cartel
- Authority / court
- Europäische Kommission
- Area of law
- Competition law · Cartels and collusion
- Legal basis
- Art. 101 AEUV, Art. 53 EWR-Abkommen
- Action
- Fine
- Status of proceedings
- unknown
- Sector
- Automotive
- Employees
- 10,000 or more
- Mitigating circumstances
- Leniency programme (Mercedes-Benz 100 %, Stellantis/Opel 50 %, Mitsubishi 30 %, Ford 20 %), 10 % settlement reduction, lesser involvement of Honda, Mazda, Mitsubishi, Suzuki
- Commission fines car manufacturers and association €458 million over end-of-life vehicles recycling cartel (IP/25/881) Press release of an authority
Checked against the official source on 25 Sep 2026 · Direct link
Report an error
31 Oct 2024 Teva Pharmaceutical Industries (Teva-Gruppe)EU: 462.6 million EUR against Teva for patent misuse and disparaging a competing medicine €462.6m
Teva abused its dominant position for the MS medicine Copaxone: it artificially extended patent protection by filing staggered divisional applications with the EPO and strategically withdrawing them, and spread misleading statements about an authorised competing product among physicians and decision-makers. Seven Member States were affected over periods of four to nine years.
Communications by sales representatives and medical affairs about competing products must be substantiated and objective; patent strategies of dominant companies require competition law review.
Disparaging statements about competing products to healthcare professionals
- Authority / court
- Europäische Kommission
- Area of law
- Competition law · Abuse of market power
- Legal basis
- Art. 102 AEUV
- Action
- Fine
- Status of proceedings
- unknown
- Sector
- Chemicals and pharmaceuticals
- Employees
- 10,000 or more
- Commission fines Teva €462.6 million over misuse of the patent system and disparagement (IP/24/5581) Press release of an authority
Checked against the official source on 25 Sep 2026 · Direct link
Report an error
19 Oct 2023 Alkaloids of Australia, Alkaloids Corporation, Boehringer, Linnea, Transo-Pharm (C2 PHARMA Kronzeuge)EU: 13.4 million EUR against pharmaceutical ingredient cartel (SNBB for Buscopan) €13.4m
From 2005 to 2019, six manufacturers and traders of the active ingredient SNBB (the base substance for Buscopan and generics) fixed minimum prices, allocated quotas and exchanged sensitive information. This was the first cartel concerning an active pharmaceutical ingredient that the Commission has sanctioned; C2 PHARMA received full immunity, and all parties reached a settlement.
Even small niche markets for active ingredients are in the spotlight – contacts with competitors about prices or volumes are off-limits.
Price and quota agreements in the trade in active ingredients
- Authority / court
- Europäische Kommission
- Area of law
- Competition law · Cartels and collusion
- Legal basis
- Art. 101 AEUV, Art. 53 EWR-Abkommen
- Action
- Fine
- Status of proceedings
- unknown
- Sector
- Chemicals and pharmaceuticals
- Mitigating circumstances
- Leniency programme (C2 PHARMA 100 %, Transo-Pharm 50 %, Linnea 30 %), 10 % settlement reduction
- Commission fines pharma companies €13,4 million in antitrust cartel settlement (IP/23/5104) Press release of an authority
Checked against the official source on 25 Sep 2026 · Direct link